Table of Contents
Thrombosis
Volume 2011 (2011), Article ID 785459, 4 pages
http://dx.doi.org/10.1155/2011/785459
Research Article

Venous Thrombosis in Multiple Sclerosis Patients after High-Dose Intravenous Methylprednisolone: The Preventive Effect of Enoxaparin

1Mehr Hospital, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran
2Loghman Hospital, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran
3Mehr Hospital, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran
4Department of Cardiology, Faculty of Medicine Damascus University, P.O. Box 8487, Damascus, Syria

Received 16 August 2011; Revised 15 November 2011; Accepted 16 November 2011

Academic Editor: J. Harenberg

Copyright © 2011 Hossein Kalanie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. M. Milligan, R. Newcombe, and D. A. S. Compston, “A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects,” Journal of Neurology Neurosurgery and Psychiatry, vol. 50, no. 5, pp. 511–516, 1987. View at Google Scholar · View at Scopus
  2. R. W. Beck, P. A. Cleary, J. D. Trobe et al., “The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis,” The New England Journal of Medicine, vol. 329, no. 24, pp. 1764–1769, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Aidi, M. P. Chaunu, V. Biousse, and M. G. Bousser, “Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteroids,” Headache, vol. 39, no. 8, pp. 559–564, 1999. View at Google Scholar · View at Scopus
  4. J. F. Albucher, C. Vuillemin-Azaïs, C. Manelfe, M. Clanet, B. Guiraud-Chaumeil, and F. Chollet, “Cerebral thrombophlebitis in three patients with probable multiple sclerosis,” Cerebrovascular Diseases, vol. 9, no. 5, pp. 298–303, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Kalanie, Y. Kholghie, G. R. Shamsai, and M. Ghorbani, “Opticospinal multiple sclerosis in Iran,” Journal of the Neurological Sciences, vol. 276, no. 1-2, pp. 130–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. W. I. McDonald, A. Compston, G. Edan et al., “Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis,” Annals of Neurology, vol. 50, no. 1, pp. 121–127, 2001. View at Publisher · View at Google Scholar
  7. J. F. Kurtzke, “Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS),” Neurology, vol. 33, no. 11, pp. 1444–1452, 1983. View at Google Scholar · View at Scopus
  8. R. L. Oliveri, P. Valentino, C. Russo et al., “Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study,” Neurology, vol. 50, no. 6, pp. 1833–1836, 1998. View at Google Scholar · View at Scopus
  9. H. Kalanie, K. Gharagozli, A. Hemmatie, M. Ghorbanie, and A. R. Kalanie, “Interferon beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in Iran,” European Neurology, vol. 52, no. 4, pp. 202–206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. British National Formulary, Venous Thrombosis, 2010.
  11. P. Averback, “Primary cerebral venous thrombosis in young adults: the diverse manifestations of an underrecognized disease,” Annals of Neurology, vol. 3, no. 1, pp. 81–86, 1978. View at Google Scholar · View at Scopus
  12. T. P. Enevoldson and R. W. Ross Russell, “Cerebral venous thrombosis: new causes for an old syndrome?” Quarterly Journal of Medicine, vol. 77, no. 284, pp. 1255–1275, 1990. View at Google Scholar · View at Scopus
  13. M. Preter, C. Tzourio, A. Ameri, and M. G. Bousser, “Long-term prognosis in cerebral venous thrombosis: follow-up of 77 patients,” Stroke, vol. 27, no. 2, pp. 243–246, 1996. View at Google Scholar · View at Scopus
  14. M. Zuber, P. Toulon, L. Marnet, and J. L. Mas, “Factor V Leiden mutation in cerebral venous thrombosis,” Stroke, vol. 27, no. 10, pp. 1721–1723, 1996. View at Google Scholar · View at Scopus
  15. E. Stolz, C. Klötzsch, F. Schlachetzki, and A. Rahimi, “High-dose corticosteroid treatment is associated with an increased risk of developing cerebral venous thrombosis,” European Neurology, vol. 49, no. 4, pp. 247–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Lane, P. M. Mannucci, K. A. Bauer et al., “U: inherited thrombophilia: part I,” Thrombosis and Haemostasis, vol. 76, pp. 651–662, 1996. View at Google Scholar
  17. N. Vandenberghe, M. Debouverie, R. Anxionnat, P. Clavelouc, S. Bouly, and M. Weber, “Cerebral venous thrombosis in four patients with multiple sclerosis,” European Journal of Neurology, vol. 10, no. 1, pp. 63–66, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Wilder-Smith, I. Kothbauer-Margreiter, B. Lämmle, M. Sturzenegger, C. Ozdoba, and S. P. Hauser, “Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis,” Journal of Neurology Neurosurgery and Psychiatry, vol. 63, no. 3, pp. 351–356, 1997. View at Google Scholar
  19. M. Maurelli, R. Bergamaschi, E. Candeloro, A. Todeschini, and G. Micieli, “Cerebral venous thrombosis and demyelinating diseases: report of a case in a clinically isolated syndrome suggestive of multiple sclerosis onset and review of the literature,” Multiple Sclerosis, vol. 11, no. 2, pp. 242–244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. S. W. Cosgriff, “Thromboembolic complications associated with ACTH and cortisone therapy,” Journal of the American Medical Association, vol. 147, no. 10, pp. 924–926, 1951. View at Google Scholar
  21. H. E. Sjoberg, M. Blomback, and P. O. Granberg, “Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing's syndrome,” Acta Medica Scandinavica, vol. 199, no. 1-2, pp. 95–98, 1976. View at Google Scholar · View at Scopus
  22. B. Wadman and I. Werner, “Thromboembolic complications during corticosteroid treatment of temporal arteritis,” The Lancet, vol. 1, no. 7756, p. 907, 1972. View at Google Scholar · View at Scopus
  23. W. Drescher, K. P. Weigert, M. H. Bünger, J. Ingerslev, C. Bünger, and E. S. Hansen, “Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs,” Journal of Orthopaedic Research, vol. 22, no. 3, pp. 501–508, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Casonato, V. Daidone, F. Sartorello et al., “Polymorphisms in von Willebrand factor gene promoter influence the glucocorticoid-induced increase in von Willebrand factor: the lesson learned from Cushing syndrome,” British Journal of Haematology, vol. 140, no. 2, pp. 230–235, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Kerachian, D. Cournoyer, E. J. Harvey et al., “Effect of high-dose dexamethasone on endothelial haemostatic gene expression and neutrophil adhesion,” Journal of Steroid Biochemistry and Molecular Biology, vol. 116, no. 3-5, pp. 127–133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. R. D. Frank, B. Altenwerth, V. M. Brandenburg, M. Nolden-Koch, and F. Block, “Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers,” Thrombosis and Haemostasis, vol. 94, no. 2, pp. 467–468, 2005. View at Google Scholar · View at Scopus
  27. S. V. Ramagopalan, C. J. Wotton, A. E. Handel, D. Yeates, and M. J. Goldacre, “Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study,” BMC Medicine, vol. 9, article 1, 2011. View at Publisher · View at Google Scholar
  28. F. R. Rosendaal, F. M. Helmerhorst, and J. P. Vandenbroucke, “Female hormones and thrombosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 2, pp. 201–210, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Städler, P. Vuadens, A. Dewarrat, R. Janzer, A. Uske, and J. Bogousslavsky, “Cerebral venous thrombosis after lumbar puncture and steroids in two patients with multiple sclerosis,” Revue Neurologique, vol. 156, no. 2, pp. 155–159, 2000. View at Google Scholar
  30. H. Kalanie, M. Kamgooyan, H. Sadeghian, and A. R. Kalanie, “Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran,” Multiple Sclerosis, vol. 6, no. 5, pp. 317–319, 2000. View at Google Scholar · View at Scopus